| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ZBH | Common Stock | Options Exercise | $817,716 | +11,522 | +28% | $70.97 | 53,402 | 13 Dec 2022 | Direct | F1, F2 |
| transaction | ZBH | Common Stock | Sale | $1,344,586 | -10,459 | -20% | $128.56 | 42,943 | 13 Dec 2022 | Direct | F1, F3 |
| transaction | ZBH | Common Stock | Sale | $137,493 | -1,063 | -2.5% | $129.34 | 41,880 | 13 Dec 2022 | Direct | F1, F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ZBH | Employee Stock Option (right to buy) | Options Exercise | $0 | -11,522 | -33% | $0.000000 | 23,045 | 13 Dec 2022 | Common Stock | 11,522 | $70.97 | Direct | F1, F5 |
| Id | Content |
|---|---|
| F1 | The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 29, 2022. |
| F2 | Includes 341 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan and pursuant to dividend reinvestment between April 27, 2022 and October 31, 2022. |
| F3 | Reflects the weighted average price of 10,459 shares of common stock of Zimmer Biomet Holdings, Inc. sold in multiple transactions on December 13, 2022 with sale prices ranging from $128.00 to 128.98 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuance, full information regarding the number of shares sold at each separate price. |
| F4 | Reflects the weighted average price of 1,063 shares of common stock of Zimmer Biomet Holdings, Inc. sold in multiple transactions on December 13, 2022 with sale prices ranging from $129.02 to $129.90 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuance, full information regarding the number of shares sold at each separate price. |
| F5 | Vested annually over four years in increments of 25% each year, commencing on March 18, 2014. |